BR112018073355A2 - gordura e seus usos médicos - Google Patents

gordura e seus usos médicos

Info

Publication number
BR112018073355A2
BR112018073355A2 BR112018073355-5A BR112018073355A BR112018073355A2 BR 112018073355 A2 BR112018073355 A2 BR 112018073355A2 BR 112018073355 A BR112018073355 A BR 112018073355A BR 112018073355 A2 BR112018073355 A2 BR 112018073355A2
Authority
BR
Brazil
Prior art keywords
fat
microfragmented
disease
medical uses
sepsis
Prior art date
Application number
BR112018073355-5A
Other languages
English (en)
Inventor
Ferdinando Maria Tremolada Carlo
Rocheteau Pierre
Original Assignee
Lipogems International S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogems International S.P.A. filed Critical Lipogems International S.P.A.
Publication of BR112018073355A2 publication Critical patent/BR112018073355A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)

Abstract

a presente invenção refere-se à gordura microfragmentada ou uma composição compreendendo a gordura microfragmentada para uso no tratamento de uma doença sistêmica, de preferência associada ou causada por sepse. além disso, a gordura microfragmentada ou a composição compreendendo a gordura microfragmentada é utilizada para o tratamento de uma doença sistêmica, inflamatória, imune ou crônica, sendo a referida doença pretendida como uma consequência de doença séptica. de preferência, a gordura microfragmentada é útil para o tratamento de ambos os estágios agudo (inicial) e tardio da sepse.
BR112018073355-5A 2016-05-13 2017-05-12 gordura e seus usos médicos BR112018073355A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUA2016A003417A ITUA20163417A1 (it) 2016-05-13 2016-05-13 Fat and medical uses thereof
IT102016000049360 2016-05-13
PCT/IB2017/052792 WO2017195156A1 (en) 2016-05-13 2017-05-12 Fat and medical uses thereof

Publications (1)

Publication Number Publication Date
BR112018073355A2 true BR112018073355A2 (pt) 2019-03-06

Family

ID=56894170

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018073355-5A BR112018073355A2 (pt) 2016-05-13 2017-05-12 gordura e seus usos médicos

Country Status (9)

Country Link
US (1) US20200316133A1 (pt)
EP (1) EP3454872A1 (pt)
JP (2) JP2019514997A (pt)
CN (1) CN109414456A (pt)
AU (1) AU2017261919B2 (pt)
BR (1) BR112018073355A2 (pt)
CA (1) CA3023814A1 (pt)
IT (1) ITUA20163417A1 (pt)
WO (1) WO2017195156A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9580678B2 (en) 2013-06-21 2017-02-28 The Regents Of The University Of California Microfluidic tumor tissue dissociation device
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
ITUA20163417A1 (it) * 2016-05-13 2017-11-13 Lipogems Int Spa Fat and medical uses thereof
KR102579835B1 (ko) 2016-06-08 2023-09-15 더 리전트 오브 더 유니버시티 오브 캘리포니아 조직 및 세포를 프로세싱하기 위한 방법 및 장치
CN114886922A (zh) * 2022-05-25 2022-08-12 温州医科大学附属第一医院 含有脂肪微片段的药物及其在慢性难愈合创面治疗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1400069B1 (it) * 2010-05-20 2013-05-17 Tremolada Dispositivo e metodo per la preparazione di tessuto, in particolare tessuto adiposo per trapianto ottenuto da materiale adiposo lobulare estratto tramite liposuzione
ITUA20163417A1 (it) * 2016-05-13 2017-11-13 Lipogems Int Spa Fat and medical uses thereof

Also Published As

Publication number Publication date
CN109414456A (zh) 2019-03-01
CA3023814A1 (en) 2017-11-16
US20200316133A1 (en) 2020-10-08
JP2019514997A (ja) 2019-06-06
ITUA20163417A1 (it) 2017-11-13
AU2017261919B2 (en) 2023-02-23
JP2022133458A (ja) 2022-09-13
AU2017261919A1 (en) 2018-11-22
WO2017195156A1 (en) 2017-11-16
EP3454872A1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
BR112018073355A2 (pt) gordura e seus usos médicos
BR112017018368A2 (pt) composições contendo rna para o tratamento de doenças tumorais
CL2018001089A1 (es) Sales de valbenazina y polimorfos de las mismas.
BR112017012327A2 (pt) benzamidas substituídas por 1,3-tiazol-2-il.
DOP2015000246A (es) Derivados de oxopiridina sustituida y usos de los mismos en el tratamiento de trastornos cardiovasculares
SV2018005610A (es) Derivados de oxopiridina sustituidos
BR112016018408A2 (pt) moléculas de anticorpo à lag-3 e usos das mesmas
BR112015030389A2 (pt) uso de i) uma fonte de proteína, ii) um prebiótico e iii) um probiótico para a fabricação de uma composição nutricional para o tratamento ou a prevenção de infecção em um indivíduo alérgico
BR112018000632A8 (pt) Moléculas de anticorpo que ligam a cd79
BR112016010166A2 (pt) métodos para usar interleucina-10 para tratar doenças e distúrbios
CL2017002825A1 (es) Formulaciones de tpp1 y métodos para tratar la enfermedad de cln2
BR112018014675A2 (pt) novos derivados de cianoindolina substituída como inibidores de nik
BR112017008039A2 (pt) derivados de pirazol como inibidores de nik
BR112017008045A2 (pt) compostos como inibidores de nik
BR112017007704A2 (pt) derivados de pirazolopirimidina como inibidores de nik
BR112017007715A2 (pt) derivados de tienopirimidina como inibidores de nik
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
BR112016025764A2 (pt) vacina de peptídeo compreendendo peptídeo ras mutante e agente quimioterapêutico
BR112017007817A2 (pt) tratamento do câncer com estimuladores imunológicos
BR112015032029A2 (pt) uso de uma composição compreendendo óleo de peixe e suco para o tratamento de inflamação
BR112017007138A2 (pt) composto, medicamento, métodos para reduzir proteína 4 de ligação ao retinol e para a profilaxia ou o tratamento de degeneração macular e/ou uma doença, e, uso de um composto.
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
BR112016015997A2 (pt) ?composições farmacêuticas que compreendem 15- hepe e métodos para tratar asma e distúrbios pulmonares com o uso das mesmas?
BR112018069682A2 (pt) métodos de tratamento para doenças colestáticas e fibróticas
CL2016002354A1 (es) Compuestos derivados de benzamida con actividad inhibidora de wnt; compuestos intermediarios; composicion farmaceutica que los comprende; uso en el tratamiento del cancer y otras enfermedades con respuesta inmune inapropiada.

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]